Atlas Venture Fund XI, L.P.

Average Profitability
<0.0001%
Insider Buys Quantity
5
Insider Buys Sum
$21.64M
Insider Sells Quantity
6
Insider Sells Sum
$389,812.32

Insider Activity of Atlas Venture Fund XI, L.P.

According to the SEC Form 4 filings, Atlas Venture Fund XI, L.P., being in a position of

  1. 10 percent owner at Xilio Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 5235 shares for $4,240,
    over all time since 2021-10-26, has bought 187500 shares for $3M, and sold 5235 shares for $4,240.

The largest purchase of all time was on 2019-06-24 and amounted to 540000 shares of Akero Therapeutics, Inc. for $8.64M.

The largest sale of all time was on 2021-12-10 and amounted to 11989 shares of Ikena Oncology, Inc. for $180,195.

Biography of Atlas Venture Fund XI, L.P.

No biography is available at this moment.

2024-02-08SaleXilio Therapeutics, Inc.
XLO
10 percent owner
1,000
0.0034%
$0.64$640+51.4%
2024-01-12SaleXilio Therapeutics, Inc.
XLO
10 percent owner
2,100
0.0088%
$0.83$1,743+18.01%
2024-01-11SaleXilio Therapeutics, Inc.
XLO
10 percent owner
2,135
0.0083%
$0.87$1,857+3.52%
2021-12-14SaleIkena Oncology, Inc.
IKNA
10 percent owner
5,959
0.0217%
$14.00$83,426-63.59%
2021-12-13SaleIkena Oncology, Inc.
IKNA
10 percent owner
8,330
0.0307%
$14.64$121,951-64.74%
2021-12-10SaleIkena Oncology, Inc.
IKNA
10 percent owner
11,989
0.0457%
$15.03$180,195-64.33%
2021-10-26PurchaseXilio Therapeutics, Inc.
XLO
10 percent owner
187,500
0.6839%
$16.00$3M-76.08%
2021-06-01PurchaseDay One Biopharmaceuticals, Inc.
DAWN
10 percent owner
1.24M
1.6574%
$6.44$8M-14.32%
2021-03-30PurchaseIkena Oncology, Inc.
IKNA
10 percent owner
125,000
2.0291%
$16.00$2M-49.34%
2021-02-01PurchaseDay One Biopharmaceuticals, Inc.
DAWN
10 percent owner
1.48M
–
$0$0
2019-06-24PurchaseAkero Therapeutics, Inc.
AKRO
10 percent owner
540,000
13.8839%
$16.00$8.64M+13.18%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.